Cargando…

MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes

BACKGROUND: miRNAs can regulate cellular survival in various cancer cell types. Recent evidence implicates the formation of lipid droplets as a hallmark event during apoptotic cell death response. It is presently unknown whether MIR494, located at 14q32 which is deleted in renal cancers, reduces cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Punashi, Haller, Edward, Sharp, Arielle, Nanjundan, Meera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722626/
https://www.ncbi.nlm.nih.gov/pubmed/26794413
http://dx.doi.org/10.1186/s12885-016-2053-3
_version_ 1782411389159079936
author Dutta, Punashi
Haller, Edward
Sharp, Arielle
Nanjundan, Meera
author_facet Dutta, Punashi
Haller, Edward
Sharp, Arielle
Nanjundan, Meera
author_sort Dutta, Punashi
collection PubMed
description BACKGROUND: miRNAs can regulate cellular survival in various cancer cell types. Recent evidence implicates the formation of lipid droplets as a hallmark event during apoptotic cell death response. It is presently unknown whether MIR494, located at 14q32 which is deleted in renal cancers, reduces cell survival in renal cancer cells and if this process is accompanied by changes in the number of lipid droplets. METHODS: 769-P renal carcinoma cells were utilized for this study. Control or MIR494 mimic was expressed in these cells following which cell viability (via crystal violet) and apoptotic cell numbers (via Annexin V/PI staining) were assessed. By western blotting, MIR494 cellular responses were validated using MIR494 antagomir and Argonaute 2 siRNA. Transmission electron microscopy (TEM) was performed in MIR494-transfected 769-P cells to identify ultrastructural changes. LipidTOX green neutral lipid staining and cholesterol measurements were conducted to assess accumulation of lipids droplets and total cholesterol levels, respectively, in MIR494 expressing 769-P cells. Indirect immunofluorescence and western analyses were also performed to examine changes in mitochondria organization. Co-transfection of MIR494 mimic with siRNA targeting LC3B and ATG7 was conducted to assess their contribution to formation of lipid droplets in MIR494-expressing cells. RESULTS: MIR494 expression reduces viability of 769-P renal cancer cells; this was accompanied by increased cleaved PARP (an apoptotic marker) and LC3B protein. Further, expression of MIR494 increased LC3B mRNA levels and LC3B promoter activity (2.01-fold; 50 % increase). Interestingly, expression of MIR494 markedly increased multilamellar bodies and lipid droplets (by TEM and validated by LipidTOX immunostaining) while reducing total cholesterol levels. Via immunocytochemistry, we observed increased LC3B-associated endogenous punctae upon MIR494 expression. In contrast to ATG7 siRNA, knockdown of LC3B reduced the numbers of lipid droplets in MIR494-expressing cells. Our results also identified that MIR494 expression altered the organization of mitochondria which was accompanied by co-localization with LC3B punctae, decreased PINK1 protein, and altered Drp1 intracellular distribution. CONCLUSION: Collectively, our findings indicate that MIR494 reduces cell survival in 769-P renal cancer cells which is accompanied by increased lipid droplet formation (which occurs in a LC3B-dependent manner) and mitochondrial changes.
format Online
Article
Text
id pubmed-4722626
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47226262016-01-23 MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes Dutta, Punashi Haller, Edward Sharp, Arielle Nanjundan, Meera BMC Cancer Research Article BACKGROUND: miRNAs can regulate cellular survival in various cancer cell types. Recent evidence implicates the formation of lipid droplets as a hallmark event during apoptotic cell death response. It is presently unknown whether MIR494, located at 14q32 which is deleted in renal cancers, reduces cell survival in renal cancer cells and if this process is accompanied by changes in the number of lipid droplets. METHODS: 769-P renal carcinoma cells were utilized for this study. Control or MIR494 mimic was expressed in these cells following which cell viability (via crystal violet) and apoptotic cell numbers (via Annexin V/PI staining) were assessed. By western blotting, MIR494 cellular responses were validated using MIR494 antagomir and Argonaute 2 siRNA. Transmission electron microscopy (TEM) was performed in MIR494-transfected 769-P cells to identify ultrastructural changes. LipidTOX green neutral lipid staining and cholesterol measurements were conducted to assess accumulation of lipids droplets and total cholesterol levels, respectively, in MIR494 expressing 769-P cells. Indirect immunofluorescence and western analyses were also performed to examine changes in mitochondria organization. Co-transfection of MIR494 mimic with siRNA targeting LC3B and ATG7 was conducted to assess their contribution to formation of lipid droplets in MIR494-expressing cells. RESULTS: MIR494 expression reduces viability of 769-P renal cancer cells; this was accompanied by increased cleaved PARP (an apoptotic marker) and LC3B protein. Further, expression of MIR494 increased LC3B mRNA levels and LC3B promoter activity (2.01-fold; 50 % increase). Interestingly, expression of MIR494 markedly increased multilamellar bodies and lipid droplets (by TEM and validated by LipidTOX immunostaining) while reducing total cholesterol levels. Via immunocytochemistry, we observed increased LC3B-associated endogenous punctae upon MIR494 expression. In contrast to ATG7 siRNA, knockdown of LC3B reduced the numbers of lipid droplets in MIR494-expressing cells. Our results also identified that MIR494 expression altered the organization of mitochondria which was accompanied by co-localization with LC3B punctae, decreased PINK1 protein, and altered Drp1 intracellular distribution. CONCLUSION: Collectively, our findings indicate that MIR494 reduces cell survival in 769-P renal cancer cells which is accompanied by increased lipid droplet formation (which occurs in a LC3B-dependent manner) and mitochondrial changes. BioMed Central 2016-01-21 /pmc/articles/PMC4722626/ /pubmed/26794413 http://dx.doi.org/10.1186/s12885-016-2053-3 Text en © Dutta et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Dutta, Punashi
Haller, Edward
Sharp, Arielle
Nanjundan, Meera
MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
title MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
title_full MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
title_fullStr MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
title_full_unstemmed MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
title_short MIR494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
title_sort mir494 reduces renal cancer cell survival coinciding with increased lipid droplets and mitochondrial changes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722626/
https://www.ncbi.nlm.nih.gov/pubmed/26794413
http://dx.doi.org/10.1186/s12885-016-2053-3
work_keys_str_mv AT duttapunashi mir494reducesrenalcancercellsurvivalcoincidingwithincreasedlipiddropletsandmitochondrialchanges
AT halleredward mir494reducesrenalcancercellsurvivalcoincidingwithincreasedlipiddropletsandmitochondrialchanges
AT sharparielle mir494reducesrenalcancercellsurvivalcoincidingwithincreasedlipiddropletsandmitochondrialchanges
AT nanjundanmeera mir494reducesrenalcancercellsurvivalcoincidingwithincreasedlipiddropletsandmitochondrialchanges